51
Views
26
CrossRef citations to date
0
Altmetric
Research Article

Detection of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)–DNA adducts in human pancreatic tissues

, , , , , , & show all
Pages 319-328 | Received 15 Sep 2005, Published online: 08 Oct 2008

References

  • American Cancer Society. 2005. Cancer facts & figures — 2005. American Cancer Society, New York, NY.
  • Anderson KE, Sinha R, Kulldorff M, Gross M, Lang NP, Barber C, Harnack L, DiMagno E, Bliss R, Kadlubar FF. Meat intake and cooking techniques: associations with pancreatic cancer. Mutation Research 2002; 506–507: 225–231
  • Butler LM, Sinha R, Millikan RC, Martin CF, Newman B, Gammon MD, Ammerman AS, Sandler RS. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. American Journal of Epidemiology 2003; 157: 434–445
  • DeBruin LS, Martos PA, Josephy PD. Detection of PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine) in the milk of healthy women. Chemical Research in Toxicology 2001; 14: 1523–1528
  • Friesen MD, Cummings DA, Garren L, Butler R, Bartsch H, Schut HA. Validation in rats of two biomarkers of exposure to the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP): PhIP–DNA adducts and urinary PhIP. Carcinogenesis 1996; 17: 67–72
  • Friesen MD, Kaderlik K, Lin D, Garren L, Bartsch H, Lang NP, Kadlubar FF. Analysis of DNA adducts of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine in rat and human tissues by alkaline hydrolysis and gas chromatography/electron capture mass spectrometry: validation by comparison with 32P-postlabeling. Chemical Research in Toxicology 1994; 7: 733–739
  • Ghadirian P, Baillargeon J, Simard A, Perret C. Food habits and pancreatic cancer: a case-control study of the Francophone community in Montreal, Canada. Cancer Epidemiology, Biomarkers and Prevention 1995; 4: 895–899
  • Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer [review]. Surgical Oncology Clinics of North America 1998; 7: 67–91
  • Hirose M, Yamaguchi T, Lin C, Kimoto N, Futakuchi M, Kono T, Nishibe S, Shirai T. Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague–Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats. Cancer Letters 2000; 155: 79–88
  • Imaida K, Hagiwara A, Yada H, Masui T, Hasegawa R, Hirose M, Sugimura T, Ito N, Shirai T. Dose-dependent induction of mammary carcinomas in female Sprague–Dawley rats with 2-amino-1-methyl-6-phenylimidazol [4,5-b] pyridine. Japanese Journal of Cancer Research 1996; 87: 1116–1120
  • Ito N, Hasegawa R, Sano M, Tamano S, Esumi H, Takayama S, Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP). Carcinogenesis 1991; 12: 1503–1506
  • Jagerstad M, Skog K, Grivas S, Olsson K. Formation of heterocyclic amines using model systems. Mutation Research 1991; 259: 219–233
  • Ji BT, Chow WH, Gridley G, McLaughlin JK, Dai Q, Wacholder S, Hatch MC, Gao YT, Fraumeni JF, Jr. Dietary factors and the risk of pancreatic cancer: a case-control study in Shanghai, China. Cancer Epidemiology, Biomarkers and Prevention 1995; 4: 885–893
  • Kaderlik KR, Minchin RF, Mulder GJ, Ilett KF, Daugaard-Jenson M, Teitel CH, Kadlubar FF. Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis 1994; 15: 1703–1709
  • Kidd LC, Stillwell WG, Yu MC, Wishnok JS, Skipper PL, Ross RK, Henderson BE, Tannenbaum SR. Urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in white, African-American, and Asian-American men in Los Angeles County. Cancer Epidemiology, Biomarkers and Prevention 1999; 8: 439–445
  • Kulp KS, Knize MG, Malfatti MA, Salmon CP, Felton JS. Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. Carcinogenesis 2000; 21: 2065–2072
  • Lightfoot TJ, Coxhead JM, Cupid BC, Nicholson S, Garner RC. Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine and benzo [a] pyrene. Mutation Research 2000; 472: 119–127
  • Lyon JL, Slattery ML, Mahoney AW, Robison LM. Dietary intake as a risk factor for cancer of the exocrine pancreas. Cancer Epidemiology, Biomarkers and Prevention 1993; 2: 513–518
  • Manabe S, Kurihara N, Wada O, Izumikawa S, Asakuno K, Morita M. Detection of a carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine in airborne particles and diesel particles. Environmental Pollution 1993; 80: 281–286
  • Manabe S, Suzuki H, Wada O, Ueki A. Detection of carcinogen 2-amino-1-methyl-6-phenylimidazole[4,5-b]pyridine (PhIP) in beer and wine. Carcinogenesis 1993; 14: 899–901
  • Manabe S, Tohyama K, Wada O, Aramaki T. Detection of carcinogen 2-amino-1-methyl-6-phenylimidazole[4,5-b]pyridine (PhIP) in cigarette smoke condensate. Carcinogenesis 1991; 12: 1945–1947
  • Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995; 76: 1671–1677
  • Ohba S, Nishi M, Miyake H. 1996. Eating habits and pancreatic cancer. International Journal of Pancreatology 20: 37–42; erratum: 153.
  • Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, Ramadani M, Henne-Bruns D, Beger HG, El-Bayoumy K. Identification of tobacco-derived compounds in human pancreatic juice. Chemical Research in Toxicology 2002; 15: 677–685
  • Schut HA, Snyderwine EG. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis [review]. Carcinogenesis 1999; 20: 353–368
  • Sinha R, Gustafson DR, Kulldorff M, Wen WQ, Cerhan JR, Zheng W. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. Journal of the National Cancer Institute 2000; 92: 1352–1354
  • Skog K, Steineck G, Augustsson K, Jagerstad M. Effect of cooking temperature on the formation of heterocyclic amines in fried meat products and pan residues. Carcinogenesis 1995; 16: 861–867
  • Takahashi S, Tamano S, Hirose M, Kimoto N, Ikeda Y, Sakakibara M, Tada M, Kadlubar FF, Ito N, Shirai T. Immunohistochemical demonstration of carcinogen-NA adducts in tissues of rats given 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP): detection in paraffin-embedded sections and tissue distribution. Cancer Research 1998; 58: 4307–4313
  • Thompson PA, Seyedi F, Lang NP, MacLeod SL, Wogan GN, Anderson KE, Tang YM, Coles B, Kadlubar FF. Comparison of DNA adduct levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype. Mutation Research 1999; 424: 263–274
  • Ushiyama H, Wakabayashi K, Hirose M, Itoh H, Sugimura T, Nagao M. Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. Carcinogenesis 1991; 12: 1417–1422
  • Wang M-Y, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, Chiao PL, Li D. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Research 1998; 58: 38–41
  • Washaw AL, Fernandez-del Castillo C. Pancreatic carcinoma [review]. New England Journal of Medicine 1992; 326: 455–465
  • Yoshimoto M, Tsutsumi M, Iki K, Sasaki Y, Tsujiuchi T, Sugimura T, Wakabayashi K, Konishi Y. Carcinogenicity of heterocyclic amines for the pancreatic duct epithelium in hamsters. Cancer Letters 1999; 143: 235–239
  • Zheng W, Gustafson DR, Sinha R, Cerhan JR, Moore D, Hong CP, Anderson KE, Kushi LH, Sellers TA, Folsom AR. Well-done meat intake and the risk of breast cancer. Journal of the National Cancer Institute 1998; 90: 1724–1729
  • Zhu J, Chang P, Bondy ML, Sahin AA, Singletary SE, Takahashi S, Shirai T, Li D. Detection of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine–DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiology Biomarkers and Prevention 2003; 12: 830–837

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.